Understanding X-Linked Hypophosphatemia: A Multidisciplinary Approach to a Rare Condition

Case Study Overview
A 46-year-old woman with a history of multiple fractures, osteoporosis, and chronic joint pain was diagnosed with XLH. Her two children also began showing symptoms at an early age, emphasizing the hereditary nature of the disease. Genetic testing revealed a pathogenic variant in the PHEX gene, confirming the diagnosis.

Key Findings from the Study

  • Genetic Basis: XLH is caused by mutations in the PHEX gene, leading to increased fibroblast growth factor 23 (FGF23) activity, which disrupts phosphate metabolism.
  • Clinical Manifestations: Patients experience rickets, osteomalacia, short stature, leg bowing, spontaneous dental abscesses, and bone pain.
  • Multidisciplinary Approach: Effective management involves endocrinologists, orthopedic surgeons, molecular pathologists, genetic counselors, and physical therapists.
  • Treatment Strategy: The patient was treated with phosphate granules and calcitriol supplementation, significantly improving her mobility and reducing pain.

For more related research articles, explore our extensive collection on X-Linked Hypophosphatemia.

Disclaimer:
This content is generated using AI assistance and should be reviewed for accuracy and compliance before considering this article and its contents as a reference. Any mishaps or grievances raised due to the reusing of this material will not be handled by the author of this article.


You may provide us with feedback in the comments section.